Abstract
Objective: This study presents real-world data from a cross-sectional follow-up survey of patients who previously received 60-day peripheral nerve stimulation (PNS) treatment for pain. Materials & methods: A survey including validated pain and other related outcome measures was distributed to patients who previously underwent implantation of temporary PNS leads for 60-day PNS treatment. Results: Among survey respondents who were at least 3 months from the start of treatment, most reported sustained clinically significant improvements in pain and/or quality of life, with the length of follow-up at the time of survey completion ranging from 3 to 30 months. Conclusion: These real-world data support recent prospective studies indicating that 60-day percutaneous PNS provides significant and sustained relief across a wide range of pain conditions.
Original language | English |
---|---|
Pages (from-to) | 611-621 |
Number of pages | 11 |
Journal | Pain Management |
Volume | 12 |
Issue number | 5 |
DOIs | |
State | Published - Jul 2022 |
Externally published | Yes |
Keywords
- 60-day PNS
- chronic pain
- neurostimulation
- peripheral nerve stimulation
- real-world evidence